Register
Register
Register

ProfileUpdated on 11 September 2024

Ready to use GMP Cell Banks for Vaccine Production

Joachim Seipelt

CBO at Nuvonis Technologies GmbH

Vienna, Austria

About

Nuvonis offers fully tested GMP banks of Vero cells and of avian CCX cells that were generated under serum-free conditions. These state-of-the-art banks can be used to immediately move into GMP production for clinical material, thus speeding up your development process. No worries about producing your own cell bank, no uncertainty in timelines, no risk.

Nuvonis offers

  • fully characterized GMP compliant cell banks

Nuvonis Key benefits

  • ready-to-use Cell Banks shorten your time to clinical evaluation and time to market by 1-2 years

  • high quality Vero Cell Bank without animal components ensures a safe and efficient production process.

  • novel quail Cell Banks CCX can be used as an alternati9ve to CEF or egg-based production in suspension.

  • save time and money

Language Tag

  • English

Industry

  • SmartProduction

Product Info

https://nuvonis.com/products/

Organisation

Nuvonis Technologies GmbH

Company

Vienna, Austria

Similar opportunities